HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 183 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $667 | +353.7% | 20,353 | +660.9% | 0.01% | +300.0% |
Q4 2022 | $147 | -100.0% | 2,675 | -84.8% | 0.00% | -77.8% |
Q2 2022 | $860,000 | +62.6% | 17,626 | +62.2% | 0.01% | +125.0% |
Q1 2022 | $529,000 | -31.2% | 10,865 | -39.7% | 0.00% | 0.0% |
Q4 2021 | $769,000 | +144.1% | 18,031 | +119.7% | 0.00% | +300.0% |
Q3 2021 | $315,000 | – | 8,206 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Valor Management LLC | 11,218,033 | $366,268,777 | 96.46% |
venBio Partners LLC | 1,035,396 | $33,805,679 | 18.74% |
Nan Fung Group Holdings Ltd | 368,665 | $12,036,912 | 8.19% |
Vivo Capital, LLC | 2,606,247 | $85,093,965 | 5.90% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 570,500 | $18,621,120 | 5.20% |
ASHFORD CAPITAL MANAGEMENT INC | 445,418 | $14,542,898 | 2.18% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 678,715 | $22,160,045 | 2.07% |
TANG CAPITAL MANAGEMENT LLC | 321,200 | $10,487,180 | 1.56% |
AlphaCentric Advisors LLC | 67,500 | $2,203,875 | 1.52% |
Paradiem, LLC | 66,995 | $2,187,387 | 0.68% |